153 related articles for article (PubMed ID: 18280568)
21. Autoantibodies purified from therapeutic preparations of intravenous immunoglobulins (IVIg) induce the formation of autoimmune complexes in normal human serum: a role in the in vivo mechanisms of action of IVIg?
Lamoureux J; Aubin E; Lemieux R
Int Immunol; 2004 Jul; 16(7):929-36. PubMed ID: 15159376
[TBL] [Abstract][Full Text] [Related]
22. Immunosuppression of EAMG by IVIG is mediated by a disease-specific anti-immunoglobulin fraction.
Fuchs S; Feferman T; Meidler R; Margalit R; Sicsic C; Brenner T; Laub O; Souroujon MC
Ann N Y Acad Sci; 2008; 1132():244-8. PubMed ID: 18567875
[TBL] [Abstract][Full Text] [Related]
23. Effect of IVIG Formulation on IgG Binding to Self- and Exo- Antigens In Vitro and In Vivo.
Cattepoel S; Gaida A; Kropf A; Nolte MW; Bolli R; Miescher SM
PLoS One; 2016; 11(8):e0161826. PubMed ID: 27561008
[TBL] [Abstract][Full Text] [Related]
24. A disease-specific fraction isolated from IVIG is essential for the immunosuppressive effect of IVIG in experimental autoimmune myasthenia gravis.
Fuchs S; Feferman T; Meidler R; Margalit R; Sicsic C; Wang N; Zhu KY; Brenner T; Laub O; Souroujon MC
J Neuroimmunol; 2008 Feb; 194(1-2):89-96. PubMed ID: 18178258
[TBL] [Abstract][Full Text] [Related]
25. Alteration of antibody specificity during isolation and storage.
Omersel J; Zager U; Kveder T; Bozic B
J Immunoassay Immunochem; 2010; 31(1):45-59. PubMed ID: 20391017
[TBL] [Abstract][Full Text] [Related]
26. [Contamination of IgG preparation for intravenous use with IgA. I. Development of ELISA tests for determination of low concentrations of IgAc, IgA1, IgA2, IgG and IgM].
Dovezenski N; Velicković Z; Tosić Lj; Nikolić G; Popović O; Romić M; Djokić M; Mijusković Z
Srp Arh Celok Lek; 1994; 122 Suppl 1():49-50. PubMed ID: 18173186
[TBL] [Abstract][Full Text] [Related]
27. What is the contents of the magic draft IVIg?
Seite JF; Shoenfeld Y; Youinou P; Hillion S
Autoimmun Rev; 2008 Jun; 7(6):435-9. PubMed ID: 18558358
[TBL] [Abstract][Full Text] [Related]
28. Functional integrity of intravenous immunoglobulin following irradiation with a virucidal dose of gamma radiation.
Tran H; Marlowe K; McKenney K; Petrosian G; Griko Y; Burgess WH; Drohan WN; Imboden MA; Kempf C; Boschetti N; Mann DM
Biologicals; 2004 Jun; 32(2):94-104. PubMed ID: 15454188
[TBL] [Abstract][Full Text] [Related]
29. Induction of natural autoantibody activity following treatment of human immunoglobulin with dissociating agents.
Bouvet JP; Stahl D; Rose S; Quan CP; Kazatchkine MD; Kaveri SV
J Autoimmun; 2001 Mar; 16(2):163-72. PubMed ID: 11247642
[TBL] [Abstract][Full Text] [Related]
30. Neutralization of human parvovirus B19 by plasma and intravenous immunoglobulins.
Modrof J; Berting A; Tille B; Klotz A; Forstner C; Rieger S; Aberham C; Gessner M; Kreil TR
Transfusion; 2008 Jan; 48(1):178-86. PubMed ID: 17900278
[TBL] [Abstract][Full Text] [Related]
31. Activation of cryptic IgG reactive with BAFF, amyloid beta peptide and GM-CSF during the industrial fractionation of human plasma into therapeutic intravenous immunoglobulins.
St-Amour I; Laroche A; Bazin R; Lemieux R
Clin Immunol; 2009 Oct; 133(1):52-60. PubMed ID: 19604724
[TBL] [Abstract][Full Text] [Related]
32. Structural study on immunoglobulin G solution after pasteurization with and without stabilizer.
Aghaie A; Pourfathollah AA; Bathaie SZ; Moazzeni SM; Pour HK; Banazadeh S
Transfus Med; 2008 Feb; 18(1):62-70. PubMed ID: 18279194
[TBL] [Abstract][Full Text] [Related]
33. Molecular structure alteration of IgG increased anticomplementary activity of intravenous immunoglobulin.
Zang XX; Sun Y; Shen F; Wang D; Zhou L; Wang J; Kung E
Zhongguo Yao Li Xue Bao; 1995 Sep; 16(5):415-9. PubMed ID: 8701757
[TBL] [Abstract][Full Text] [Related]
34. Intravenous immunoglobulin: exploiting the potential of natural antibodies.
Kaveri SV
Autoimmun Rev; 2012 Sep; 11(11):792-4. PubMed ID: 22349620
[TBL] [Abstract][Full Text] [Related]
35. Demonstration of the IgG antibody repertoire against the bacteria Escherichia coli in Chinese intravenous immunoglobulins.
Ye S; Lei M; Jiang P; Liu F; Wang Z; Cao H; Du X; Yuan J; Chen Y; Ma L; Li C
J Pharm Biomed Anal; 2017 Jan; 133():8-14. PubMed ID: 27792896
[TBL] [Abstract][Full Text] [Related]
36. Serum antibody levels against Porphyromonas gingivalis extract and its chromatographic fraction in chronic and aggressive periodontitis.
Trindade SC; Gomes-Filho IS; Meyer RJ; Vale VC; Pugliese L; Freire SM
J Int Acad Periodontol; 2008 Apr; 10(2):50-8. PubMed ID: 18564729
[TBL] [Abstract][Full Text] [Related]
37. [Contamination of IgG preparation for intravenous use with IgA. II. Removal of IgA1 from IgG preparation using affinity chomatography on lectin jacalin columns].
Dovezenski N; Velicković Z; Tosić Lj; Nikolić G; Popović O; Romić M; Djokić M; Mijusković Z
Srp Arh Celok Lek; 1994; 122 Suppl 1():51-2. PubMed ID: 18173187
[TBL] [Abstract][Full Text] [Related]
38. On the presence of antibodies against bovine, equine and poultry immunoglobulins in human IgG preparations, and its implications on antivenom production.
Sevcik C; Díaz P; D'Suze G
Toxicon; 2008 Jan; 51(1):10-6. PubMed ID: 18045635
[TBL] [Abstract][Full Text] [Related]
39. Suppression of experimental autoimmune myasthenia gravis by intravenous immunoglobulin and isolation of a disease-specific IgG fraction.
Fuchs S; Feferman T; Zhu KY; Meidler R; Margalit R; Wang N; Laub O; Souroujon MC
Ann N Y Acad Sci; 2007 Sep; 1110():550-8. PubMed ID: 17911471
[TBL] [Abstract][Full Text] [Related]
40. Stability over 36 months of a new liquid 10% polyclonal immunoglobulin product (IgPro10, Privigen) stabilized with L-proline.
Cramer M; Frei R; Sebald A; Mazzoletti P; Maeder W
Vox Sang; 2009 Apr; 96(3):219-25. PubMed ID: 19207169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
